MedPath

Low Laser Therapy and Hyaluronic Acid as an Adjunct to Non-surgical Periodontal Therapy

Not Applicable
Recruiting
Conditions
Periodontitis
Interventions
Device: SRP+HA
Device: SRP
Device: SRP+LASER (Dentsply Sirona - SIROLaser Blue)
Registration Number
NCT05907161
Lead Sponsor
University of Ljubljana
Brief Summary

Periodontal disease is an oral disease characterized by microbially associated, host-mediated inflammation of the periodontium. In the treatment of periodontal disease, conventional periodontal therapy includes both surgical and non-surgical approaches. Non-surgical therapy (i.e. scaling and root planing - SRP) remains an essential part of periodontal therapy. Here, diseased root surface debridement utilizing different hand and ultrasonic instrumentation is performed to facilitate periodontal re-attachment and to reduce the bacterial mass in the periodontal pocket.

In the last decade, the use of lasers (light amplification by stimulated emission of radiation) has occupied part of the dialogue within periodontology due to several proposed advantages. In the arena of periodontology, laser use, as an adjunct to non-surgical therapy, was demonstrated to enhance periodontal healing; however, it is still the matter of debate. Among laser applications, low-level laser therapy is recommended for its pain-reducing, woundhealing and anti-inflammatory effects.

Hyaluronic acid is a non-sulfated glycosaminoglycan and a major component of the extracellular matrix. It is found in various body fluids, such as gingival crevicular fluid, saliva, serum and synovial fluid. Anti-inflammatory, anti-edematous and anti-bacterial activities of hyaluronic acid have been investigated in dentistry, specially in periodontology.

Detailed Description

Each participant will be assigned in one of three groups. In each group there will be 15 participants. Different treatment protocols will be carried in each group as follows: group one (scaling and root planing), group two (scaling and root planing + LASER), group three (scaling and root planing + hyaluronic acid). Under local anesthesia we will perform scaling and root planing of the teeth in two sessions. The procedure be made with the use of ultrasonic (PiezoLED Scaler, KaVo, Biberach, DE) and hand instruments (Gracey, Hu Friedy, Chicago, IL, USA). In group one, only scaling and root planning (SRP) will be made. In group two, the use of a diode laser (Dentsply Sirona - SIROLaser Blue) will be added to the therapy. In group three, after the performance of SRP, a gel containing hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic acid gel) will be applied intrasulcular.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • systemically healthy
  • nonsmokers
  • untreated periodontal disease (stage 3, grade B or C)
  • plaque index will not exceed 20%
  • at least 20 teeth in oral cavity
Exclusion Criteria
  • systemic diseases with impact on periodontal health
  • medication with impact on periodontal health
  • smokers
  • pregnant and lactating women
  • patients treated with antibiotics in the last 12 months
  • patients who had undergone periodontal treatment in the last year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SRP+HASRP+HAThe SRP+HA group will receive non-surgical periodontal therapy using an ultrasonic device and curettes in two sessions. After session 2, a gel containing hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic acid gel) will be applied intrasulcular to all sites with PD ≥ 4mm.
SRPSRPThe SRP group will receive non-surgical periodontal therapy using an ultrasonic device and curettes in two sessions.
SRP+LASERSRP+LASER (Dentsply Sirona - SIROLaser Blue)The SRP+LASER group will receive non-surgical periodontal therapy using an ultrasonic device and curettes in two sessions. After session 2, irradiation with a diode laser (Dentsply Sirona - SIROLaser Blue) will be applied intrasulcular to all sites with PD ≥ 4mm.
Primary Outcome Measures
NameTimeMethod
Probing pocket depth reduction3 months, 6 months

Change in probing pocket depth after treatment

Secondary Outcome Measures
NameTimeMethod
Clinical attachment level gain3 months, 6 months

Change in clinical attachment level after treatment

Residual diseased site number3 months, 6 months

No of sites with PD ≥ 4mm and bleeding on probing after treatment

Bleeding on probing percentage reduction3 months, 6 months

Bleeding after measurement of pocket depth, reduction after treatment

Trial Locations

Locations (1)

Univerity Medical Center Ljubljana

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath